insights_auto
Why is QDEL up 4.43%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
$10.84
arrow_upward
+4.43%(+0.46) 1D
Oct 2, 12:53:11 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.67
High
$11.18
Low
$10.46
Mkt. cap
743.36M
Avg. vol.
1.42M
Volume
690.63K
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
Open
$10.67
High
$11.18
Low
$10.46
Mkt. cap
743.36M
Avg. vol.
1.42M
Volume
690.63K
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
marketscreener.com
·
34 minutes ago
Dow's laggard, Nike disappoints again with sales and guidance
FXEmpire
·
21 minutes ago
Nasdaq Index: Record High as Weak Payrolls Cut Rate-Hike Bets and Yields Fall
24/7 Wall St.
·
54 minutes ago
S&P 500 at 7,718 Midday: Tech Takes the Lead With Nasdaq Up 1.1%
ChartMill
·
2 hours ago
These S&P500 stocks are gapping in today's session
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com